SCHEMBL9912745

SCHEMBL9912745

O=S(=O)(Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F)c1cccc(Cl)c1Cl

nearest known ligand 0.80

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BRAF P15056 20/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9912753 0.94 BRAF (0.80) BRAF
SCHEMBL9912795 0.94 BRAF (0.79) BRAF
SCHEMBL9912759 0.92 BRAF (0.81) BRAF
SCHEMBL9912783 0.88 BRAF (0.80) BRAF
SCHEMBL9912775 0.87 BRAF (0.81) BRAF
SCHEMBL9912747 0.87 BRAF (0.79) BRAF
SCHEMBL14964670 0.87 BRAF (0.70) BRAF
SCHEMBL15300284 0.86 BRAF (0.62) BRAF
SCHEMBL9912781 0.86 BRAF (0.80) BRAF
SCHEMBL9912803 0.86 BRAF (0.80) BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9216981-B2 Purinylpyridinylamino-2,4-difluorophenyl sulfonamide derivative, pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition with inhibitory activity against Raf kinase, containing same as active ingredient MEDPACTO, INC. (KR) 2015-12-22 US disclosed
WO-2012074249-A2 NOVEL PURINYLPYRIDINYLAMINO-2,4-DIFLUOROPHENYL SULFONAMIDE DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION WITH INHIBITORY ACTIVITY AGAINST RAF KINASE, CONTAINING SAME AS ACTIVE INGREDIENT 주식회사 유아이 (KR) 2012-06-07 WO disclosed